Filtered By:
Condition: Patent Foramen Ovale
Drug: Topamax
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Effect of Percutaneous Closure of Patent Foramen Ovale on Post-Procedural Arrhythmias
Atrial arrhythmias after percutaneous patent foramen ovale (PFO) closure, including atrial fibrillation (AF), has been consistently reported in different series suggesting a causal link between mechanical closure of PFO and the new onset of post-procedural arrhythmias (1,2,3). We have systematically assessed the effect of percutaneous PFO closure upon the development of post-procedural arrhythmias in 221 consecutive patients (144 women; mean age 48 ± 13 years) undergoing percutaneous PFO closure. At clinical evaluation, no patient had symptoms indicative or suggestive of arrhythmias. Indications for closure were the prese...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 16, 2013 Category: Cardiology Source Type: research
